MDL Judge Approves $345M Pfizer EpiPen Consumer, Third-Party Payer Settlement

Mealey's (November 18, 2021, 1:18 PM EST) -- KANSAS CITY, Kan. — The judge overseeing the EpiPen multidistrict litigation on Nov. 17 granted final approval to Pfizer Inc.’s $345 million consumer and third-party payer class settlement, along with $115...
To view the full article, register now.